"The Report Male
Hypogonadism Global Clinical Trials Review, H1, 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report,
Male Hypogonadism Global
Clinical Trials Review, H1, 2016" provides an overview of Male
Hypogonadism clinical trials scenario. This report provides top line
data relating to the clinical trials on Male Hypogonadism. Report
includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe. The report offers coverage
of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/716934
Scope
- The report provides a
snapshot of the global clinical trials landscape
- Report provides top level
data related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top
companies involved and enlists all trials (Trial title, Phase, and
Status) pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides
enrollment trends for the past five years
- Report provides latest news
for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Browse
Latest News at http://www.marketresearchreports.biz/articles
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing
to Clinical Trials in Europe 11
Top Countries Contributing to
Clinical Trials in North America 12
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to
Clinical Trials in Central and South America 14
Clinical Trials by G7
Countries: Proportion of Male Hypogonadism to Male Health Clinical
Trials 15
Clinical Trials by Phase in G7
Countries 16
Clinical Trials in G7 Countries
by Trial Status 17
Clinical Trials by E7
Countries: Proportion of Male Hypogonadism to Male Health Clinical
Trials 18
Clinical Trials by Phase in E7
Countries 19
Clinical Trials in E7 Countries
by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status
23
Clinical Trials by End Point
Status 24
Subjects Recruited Over a
Period of Time 25
Clinical Trials by Sponsor Type
26
Prominent Sponsors 27
Top Companies Participating in
Male Hypogonadism Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on
Male Hypogonadism 31
Mar 28, 2016: Lipocine
Announces the Presentation of Clinical Data for LPCN 1021, Its Oral
Testosterone Replacement Therapy Product Candidate, at the American
Society of Andrology 41st Annual Conference 31
Mar 28, 2016: Lipocine
Announces the Presentation of Clinical Data for LPCN 1021, Its Oral
Testosterone Replacement Therapy Product Candidate, at ENDO 2016 31
Mar 16, 2016: Antares Pharma
Announces Completion of the 52 Week QuickShot Phase 3 Study in
Testosterone Deficient Men 31
Feb 17, 2016: New Research
Finds Testosterone Treatment Improves Sexual Activity, Physical
Function in Men Over 65 Years Old 32
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment